NCT00733525

Brief Summary

This study will compare the medical and cost effectiveness of a stepped approach, including self-help and drug therapies, to the current best available care for bulimia nervosa.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
293

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2000

Longer than P75 for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2000

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2005

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2005

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

August 12, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 13, 2008

Completed
Last Updated

November 1, 2019

Status Verified

October 1, 2019

Enrollment Period

4.6 years

First QC Date

August 12, 2008

Last Update Submit

October 30, 2019

Conditions

Keywords

Bulimia Nervosa

Outcome Measures

Primary Outcomes (1)

  • Eating disorders examination

    Measured at baseline and Weeks 10, 18, 36, and 62

Secondary Outcomes (4)

  • Records of health care, medications, and treatments

    Measured at baseline and Weeks 10, 18, 36, and 62

  • Height, weight, and body mass index

    Measured at baseline, Week 8, and Week 62

  • Battery of self-report questionnaires

    Measured at baseline and Weeks 10, 18, 36, and 62

  • Questionnaire on time lost to bulimia, completed by a family member

    Measured at baseline and after 18 weeks of treatment

Study Arms (2)

Stepped Care

EXPERIMENTAL

Participants will receive guided self-help with nine clinician checkups, followed by fluoxetine if nonresponsive, followed by cognitive behavioral therapy if still nonresponsive.

Behavioral: Cognitive Behavioral TherapyDrug: FluoxetineBehavioral: Guided Self-Help

Cognitive Behavioral Therapy

ACTIVE COMPARATOR

Participants will receive 20 sessions of cognitive behavioral therapy with the addition of fluoxetine at interim points.

Behavioral: Cognitive Behavioral TherapyDrug: Fluoxetine

Interventions

Therapy focusing on skills needed to alter eating patterns

Cognitive Behavioral TherapyStepped Care

20 mg/day of fluoxetine, which can be incrementally increased to 80 mg/day

Also known as: Prozac
Cognitive Behavioral TherapyStepped Care

Manual designed to impart teachings of cognitive behavioral therapy

Stepped Care

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of bulimia nervosa

You may not qualify if:

  • Weight less than 85% of ideal
  • Current substance abuse or dependence
  • Pregnant
  • Currently receiving psychotherapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Stanford University

Palo Alto, California, 94305, United States

Location

University of Minnesota Minneapolis, MN

Minneapolis, Minnesota, 55455, United States

Location

Cornell University; White Plains, NY

White Plains, New York, 10605, United States

Location

University of North Dakota / Neuropsychiatric Research Institute

Fargo, North Dakota, 58103, United States

Location

Related Publications (1)

  • Mitchell JE, Agras S, Crow S, Halmi K, Fairburn CG, Bryson S, Kraemer H. Stepped care and cognitive-behavioural therapy for bulimia nervosa: randomised trial. Br J Psychiatry. 2011 May;198(5):391-7. doi: 10.1192/bjp.bp.110.082172. Epub 2011 Mar 17.

MeSH Terms

Conditions

Feeding and Eating DisordersBulimia Nervosa

Interventions

Cognitive Behavioral TherapyFluoxetine

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesPropylaminesAminesOrganic Chemicals

Study Officials

  • Stewart Agras, MD

    Stanford University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2008

First Posted

August 13, 2008

Study Start

September 1, 2000

Primary Completion

April 1, 2005

Study Completion

August 1, 2005

Last Updated

November 1, 2019

Record last verified: 2019-10

Locations